Ospedale Villa Scassi - Sampierdarena-ASL3-Azienda sociosanitaria ligure
- Address
- lock Available on a paid plan
Musculoskeletal Diseases
At Ospedale Villa Scassi, researchers are exploring new options for patients with knee osteoarthritis, focusing on pain relief and joint safety through a locally administered therapy.
- Intra‑articular treatment dose‑finding study
- Pain score reduction using visual analogue scale
- Comprehensive safety monitoring of joint injections
The program involves four investigators and aims to improve quality of life for individuals struggling with chronic knee pain.
Neoplasms
A clinical effort is underway to assess an immunotherapy agent in patients diagnosed with malignant pleural mesothelioma, evaluating its impact on disease‑free survival after surgery.
- Immunotherapy effectiveness in pleural cancer
- Post‑operative treatment outcomes
- Analysis of disease‑free survival rates
This study contributes to the limited therapeutic options for this aggressive tumor type and involves a multidisciplinary team of four investigators.
Skin and Connective Tissue Diseases
The site is testing a novel topical formulation, EscharEx, for patients with venous leg ulcers, aiming to enhance wound debridement and prepare the wound bed for healing.
- Topical agent evaluation for ulcer debridement
- Accelerated wound‑healing processes
- Safety profile of the new wound‑care product
With three active trials, the research seeks to provide better management options for chronic leg ulcers and improve patient outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ospedale Villa Scassi - Sampierdarena-ASL3-Azienda sociosanitaria ligure
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Intra-Articular Clodronate Disodium for Efficacy and Tolerability in Patients with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial | Spa Societa Prodotti Antibiotici S.p.A. | Phase IV | Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atezolizumab | 1 | Unknown | 2024-12-17 | 2024-12-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.